Evaluation and Management of Polycystic Ovary Syndrome

Journal of Pediatric Health Care

Volumn 23, Issue 5, 2009, Pages 337-343

  Benjamins, Laura J ^a   Barratt, Michelle S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; NURSE PRACTITIONER; OVARY POLYCYSTIC DISEASE;

DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; NURSE PRACTITIONERS; POLYCYSTIC OVARY SYNDROME;

EID: 69249166154     PISSN: 08915245     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pedhc.2009.06.001     Document Type: Article

References (36)

1. Apter D., and Vihko R. Serum pregnenolone, progesterone, 17-hydroxyprogesterone, testosterone and 5 alpha-dihydrotestosterone during female puberty. Journal of Clinical Endocrinology & Metabolism 45 (1977) 1039-1048
2. Asuncion M., Calvo R.M., San Millan J.L., Sancho J., Avila S., and Escobar-Morreale H.F. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. Journal of Clinical Endocrinology & Metabolism 85 (2000) 2434-2438
3. Azziz R. Differential diagnosis and evaluation of hyperandrogenism. In: Hall J.E., and Nieman L.K. (Eds). Handbook of diagnostic endocrinology (2003), Humana Press, Totowa, NJ 323-330
4. Azziz R., Carmina E., Dewailly D., Diamanti-Kandarakis E., Escobar-Morreale H.F., Futterweit W., et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: The complete task force report. Fertility & Sterility 91 (2009) 456-488
5. Azziz R., Sanchez L.A., Knochenhauer E.S., Moran C., Lazenby J., Stephens K.C., et al. Androgen excess in women: Experience with over 1000 consecutive patients. Journal of Clinical Endocrinology & Metabolism 89 (2004) 453-462
6. Barbieri R.L. Hyperandrogenic disorders. Clinical Obstetrics & Gynecology 33 (1990) 640-654
7. Barbieri R.L. Metformin for the treatment of polycystic ovary syndrome. Obstetrics & Gynecology 101 (2003) 785-793
8. Bridger T., MacDonald S., Baltzer F., and Rodd C. Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome. Archives of Pediatrics & Adolescent Medicine 160 (2006) 241-246
9. Despres J.P., Lamarche B., Mauriege P., Cantin B., Dagenais G.R., Moorjani S., et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. New England Journal of Medicine 334 (1996) 952-957
10. Diamanti-Kandarakis E. Polycystic ovarian syndrome: Pathophysiology, molecular aspects and clinical implications. Expert Reviews in Molecular Medicine 10 (2008) e3
11. Ehrmann D.A. Polycystic ovary syndrome. New England Journal of Medicine 352 (2005) 1223-1236 [see comment]
12. Ehrmann D.A., Barnes R.B., Rosenfield R.L., Cavaghan M.K., and Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22 (1999) 141-146
13. Elmer K.B., and George R.M. HAIR-AN syndrome: A multisystem challenge. American Family Physician 63 (2001) 2385-2390
14. Emans S.J. Androgen abnormalities in the adolescent girl. In: Emans S.J., Laufer M.R., and Goldstein D.P. (Eds). Pediatric and adolescent gynecology. 5th (2005), Lippincott Williams & Wilkins, Philadelphia, PA 287-330
15. Fleming R., Hopkinson Z.E., Wallace A.M., Greer I.A., and Sattar N. Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. Journal of Clinical Endocrinology & Metabolism 87 (2002) 569-574
16. Friedman C.I., Richards S., and Kim M.H. Familial acanthosis nigricans. A longitudinal study. Journal of Reproductive Medicine 32 (1987) 531-536
17. Granberry M.C., and Fonseca V.A. Insulin resistance syndrome: Options for treatment. Southern Medical Journal 92 (1999) 2-15
18. Grundy S.M., Hansen B., Smith Jr. S.C., Cleeman J.I., Kahn R.A., Heart Association A., Heart, Lung N., Institute B., and American Diabetes Association. Clinical management of metabolic syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 109 (2004) 551-556
19. Iuorno M.J., Baillargeon J.P., and Nestler J.E. Polycystic ovary syndrome. In: Leppert P.C., and Peipert J.F. (Eds). Primary Care for Women (2nd) (pp. 262-266) (2007), Lippincott Williams & Wilkins, Philadelphia, PA
20. Kay J.P., Alemzadeh R., Langley G., D'Angelo L., Smith P., and Holshouser S. Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metabolism: Clinical & Experimental 50 (2001) 1457-1461
21. Knochenhauer E.S., Key T.J., Kahsar-Miller M., Waggoner W., Boots L.R., and Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study. Journal of Clinical Endocrinology & Metabolism 83 (1998) 3078-3082
22. Legro R.S., Gnatuk C.L., Kunselman A.R., and Dunaif A. Changes in glucose tolerance over time in women with polycystic ovary syndrome: A controlled study. Journal of Clinical Endocrinology & Metabolism 90 (2005) 3236-3242
23. Molnar D. The prevalence of the metabolic syndrome and type 2 diabetes mellitus in children and adolescents. International Journal of Obesity & Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 28 Suppl. 3 (2004) S70-S74
24. Morin-Papunen L.C., Koivunen R.M., Ruokonen A., and Martikainen H.K. Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome. Fertility & Sterility 69 (1998) 691-696
25. Nestler J.E. Metformin for the treatment of the polycystic ovary syndrome. New England Journal of Medicine 358 (2008) 47-54 [see comment]
26. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., and Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 (2006) 1549-1555
27. Patalano A., Brancato V., and Mantero F. Adrenocortical cancer treatment. Hormone Research 71 Suppl. 1 (2009) 99-104
28. Speroff L., and Fritz M.A. Anovulation and the polycystic ovary. Clinical gynecologic endocrinology and infertility. 7th (2005), Lippincott Williams & Wilkins, Philadelphia, PA 465-498
29. Speroff L., and Fritz M.A. Dysfunctional uterine bleeding. Clinical gynecologic endocrinology and infertility. 7th (2005), Lippincott Williams & Wilkins, Philadelphia, PA 554
30. Speroff L., and Fritz M.A. Hirsutism. Clinical gynecologic endocrinology and infertility. 7th (2005), Lippincott Williams & Wilkins, Philadelphia, PA 552
31. Stein I.F., and Levanthal M. Amenorrhea associated with bilateral polycystic ovaries. American Journal of Obstetrics and Gynecology 29 (1935) 181-185
32. The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 19 (2004) 41-47
33. Thompson P.D., Buchner D., Pina I.L., Balady G.J., Williams M.A., Marcus B.H., et al., American Heart Association Council on Clinical Cardiology Subcommittee on Exercise, Rehabilitation, and Prevention, & American Heart Association Council on Nutrition, Physical Activity, and Metabolism Subcommittee on Physical Activity. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: A statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 107 (2003) 3109-3116
34. Verkauf B.S., Von Thron J., and O'Brien W.E. Clitoral size in normal women. Obstetrics and Gynecology 80 (1992) 41
35. Vihko R., and Apter D. Endocrine characteristics of adolescent menstrual cycles: Impact of early menarche. Journal of Steroid Biochemistry 20 (1984) 231-236
36. Zacharias L., Wurtman R.J., and Schatzoff M. Sexual maturation in contemporary American girls. American Journal of Obstetrics & Gynecology 108 (1970) 833-846